Related Experiment Videos
[Chronic depressive syndrome--characteristics and therapeutic possibilities]
E Umann1, H Kulawik, A Rindtorff
1Lehrstuhl Psychiatrie, Bereichs Medizin (Charité), Humboldt-Universität zu Berlin.
Psychiatrie, Neurologie, Und Medizinische Psychologie
|November 1, 1990
Summary
Certain depression treatments, including lithium and electroconvulsive therapy, may prolong hospital stays. This study found no interventions that shorten inpatient duration for depressive syndromes.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Context:
- Analysis of 322 patients with depressive syndromes and 413 inpatient treatments from 1978-1987.
- Investigating therapeutic factors influencing inpatient treatment duration.
Purpose:
- To identify therapeutic factors associated with prolonged or reduced hospital stays in patients with depressive syndromes.
- To evaluate the impact of specific treatments on the length of inpatient care.
Summary:
- Therapeutic interventions identified tend to lengthen inpatient hospitalisation periods.
- No therapeutic factors were found to reduce the length of hospital stay.
- Lithium treatment, Netofenazat, electroconvulsive therapy (ECT) during initial disorder, and optimal simultaneous thymoleptic treatment were associated with increased hospital stay.
Impact:
- Findings suggest current therapeutic approaches may contribute to longer inpatient durations for depression.
- Highlights the need for research into interventions that can shorten hospital stays for depressive syndromes.
- Informs clinical practice regarding treatment choices and their potential impact on patient chronicity.